In vitro emergence of fluoroquinolone resistance in Cutibacterium (formerly Propionibacterium ) acnes and molecular characterization of mutations in the gyrA gene-Reference-Cited by-同舟云学术

In vitro emergence of fluoroquinolone resistance in Cutibacterium (formerly Propionibacterium ) acnes and molecular characterization of mutations in the gyrA gene

Published:2017-10 Issue: Volume:47 Page:194-200
ISSN:1075-9964
Container-title:Anaerobe
language:en
Short-container-title:Anaerobe

Author:

Takoudju Eve-Marie,Guillouzouic Aurélie,Kambarev Stanimir,Pecorari Frédéric,Corvec Stéphane^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference40 articles.

1. Propionibacterium acnes: an update on its role in the pathogenesis of acne;Beylot;J. Eur. Acad. Dermatol. Venereol. JEADV,2014

2. Topical acne treatments in Europe and the issue of antimicrobial resistance;Leccia;J. Eur. Acad. Dermatol. Venereol. JEADV,2015

3. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance;Aubin;Méd. Mal. Infect.,2014

4. Significance of Propionibacterium acnes-positive samples in spinal instrumentation;Bémer;Spine,2008

5. Propionibacterium acnes: an underestimated pathogen in implant-associated infections;Portillo;Biomed. Res. Int.,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of antibiotic-resistant Cutibacterium acnes (formerly Propionibacterium acnes) isolates, A systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-08

2. Conserved Evolutionary Trajectory Can Be Perturbed to Prevent Resistance Evolution under Norfloxacin Pressure by Forcing Mycobacterium smegmatis on Alternate Evolutionary Paths;ACS Infectious Diseases;2024-07-03

3. Cutibacterium (previously Propionibacterium) acnes and disease;Molecular Medical Microbiology;2024

4. In Vivo Emergence of Dual Resistance to Rifampin and Levofloxacin in Osteoarticular Cutibacterium avidum;Microbiology Spectrum;2023-08-17

5. Temporally variable drug profiles select for diverse adaptive pathways despite conservation of efflux-based resistance mechanism;2023-05-22